50 0 2 0 2 B-lower_bound
- 3 4 3 4 O
95 5 7 5 7 B-upper_bound
years 8 13 8 13 I-upper_bound
old 14 17 14 17 O

Abnormal 0 8 18 26 O
liver 9 14 27 32 B-clinical_variable
function 15 23 33 41 I-clinical_variable
test 24 28 42 46 I-clinical_variable
( 29 30 47 48 O
greater 30 37 48 55 O
than 38 42 56 60 O
2 43 44 61 62 B-lower_bound
times 45 50 63 68 I-lower_bound
the 51 54 69 72 I-lower_bound
upper 55 60 73 78 I-lower_bound
limit 61 66 79 84 I-lower_bound
of 67 69 85 87 O
normal 70 76 88 94 O
for 77 80 95 98 O
alanine 81 88 99 106 B-clinical_variable
aminotransferase 89 105 107 123 I-clinical_variable
( 106 107 124 125 I-clinical_variable
ALT 107 110 125 128 I-clinical_variable
) 110 111 128 129 I-clinical_variable
or 112 114 130 132 O
aspartate 115 124 133 142 B-clinical_variable
aminotransferase 125 141 143 159 I-clinical_variable
( 142 143 160 161 I-clinical_variable
AST 143 146 161 164 I-clinical_variable
) 146 147 164 165 I-clinical_variable

Any 0 3 166 169 O
unstable 4 12 170 178 O
serious 13 20 179 186 O
co 21 23 187 189 O
- 23 24 189 190 O
existing 24 32 190 198 O
medical 33 40 199 206 B-chronic_disease
condition(s 41 52 207 218 I-chronic_disease
) 52 53 218 219 I-chronic_disease
including 54 63 220 229 O
but 64 67 230 233 O
not 68 71 234 237 O
limited 72 79 238 245 O
to 80 82 246 248 O
myocardial 83 93 249 259 B-chronic_disease
infarction 94 104 260 270 I-chronic_disease
, 104 105 270 271 O
coronary 106 114 272 280 O
artery 115 121 281 287 O
disease 122 129 288 295 O
requiring 130 139 296 305 O
coronary 140 148 306 314 B-treatment
bypass 149 155 315 321 I-treatment
surgery 156 163 322 329 I-treatment
, 163 164 329 330 O
unstable 165 173 331 339 B-chronic_disease
angina 174 180 340 346 I-chronic_disease
, 180 181 346 347 O
clinically 182 192 348 358 O
evident 193 200 359 366 O
congestive 201 211 367 377 B-chronic_disease
heart 212 217 378 383 I-chronic_disease
failure 218 225 384 391 I-chronic_disease
within 226 232 392 398 O
6 233 234 399 400 B-upper_bound
months 235 241 401 407 I-upper_bound
prior 242 247 408 413 I-upper_bound
to 248 250 414 416 O
the 251 254 417 420 O
screening 255 264 421 430 O
visit 265 270 431 436 O

Current 0 7 437 444 O
smoker 8 14 445 451 O
or 15 17 452 454 O
user 18 22 455 459 O
of 23 25 460 462 O
nicotine 26 34 463 471 O
- 34 35 471 472 O
containing 35 45 472 482 O
products 46 54 483 491 O
, 54 55 491 492 O
such 56 60 493 497 O
as 61 63 498 500 O
chewing 64 71 501 508 O
tobacco 72 79 509 516 O
, 79 80 516 517 O
nicotine 81 89 518 526 O
patch 90 95 527 532 O
or 96 98 533 535 O
gum 99 102 536 539 O
for 103 106 540 543 O
the 107 110 544 547 O
past 111 115 548 552 B-upper_bound
2 116 117 553 554 I-upper_bound
months 118 124 555 561 I-upper_bound

Current 0 7 562 569 O
untreated 8 17 570 579 O
major 18 23 580 585 O
depression 24 34 586 596 O
defined 35 42 597 604 O
by 43 45 605 607 O
Geriatric 46 55 608 617 B-clinical_variable
Depression 56 66 618 628 I-clinical_variable
Scale 67 72 629 634 I-clinical_variable
> 73 74 635 636 O
20 75 77 637 639 B-lower_bound

Currently 0 9 640 649 O
a 10 11 650 651 O
user 12 16 652 656 O
of 17 19 657 659 O
the 20 23 660 663 O
following 24 33 664 673 O
illicit 34 41 674 681 O
drugs 42 47 682 687 O
: 47 48 687 688 O
cocaine 49 56 689 696 O
, 56 57 696 697 O
methylenedioxymethamphetamine 58 87 698 727 O
( 88 89 728 729 O
MDMA 89 93 729 733 O
) 93 94 733 734 O
( 95 96 735 736 O
ecstasy 96 103 736 743 O
) 103 104 743 744 O
, 104 105 744 745 O
heroin 106 112 746 752 O
and 113 116 753 756 O
other 117 122 757 762 O
opioids 123 130 763 770 O
or 131 133 771 773 O
has 134 137 774 777 O
a 138 139 778 779 O
history 140 147 780 787 O
of 148 150 788 790 O
drug 151 155 791 795 O
or 156 158 796 798 O
alcohol 159 166 799 806 O
abuse 167 172 807 812 O
within 173 179 813 819 O
the 180 183 820 823 O
past 184 188 824 828 B-upper_bound
5 189 190 829 830 I-upper_bound
years 191 196 831 836 I-upper_bound

Currently 0 9 837 846 O
taking 10 16 847 853 O
any 17 20 854 857 O
concomitant 21 32 858 869 B-treatment
hepatotoxic 33 44 870 881 I-treatment
drugs 45 50 882 887 I-treatment
such 51 55 888 892 O
as 56 58 893 895 O
allopurinol 59 70 896 907 B-treatment
, 70 71 907 908 O
methyldopa 72 82 909 919 B-treatment
and 83 86 920 923 O
sulfasalazine 87 100 924 937 B-treatment

Currently 0 9 938 947 O
taking 10 16 948 954 O
medications 17 28 955 966 B-treatment
that 29 33 967 971 O
either 34 40 972 978 O
have 41 45 979 983 O
evidence 46 54 984 992 O
of 55 57 993 995 O
glutamatergic 58 71 996 1009 O
activity 72 80 1010 1018 O
or 81 83 1019 1021 O
has 84 87 1022 1025 O
previous 88 96 1026 1034 B-treatment
MRS 97 100 1035 1038 I-treatment
evidence 101 109 1039 1047 O
of 110 112 1048 1050 O
effects 113 120 1051 1058 O
on 121 123 1059 1061 O
brain 124 129 1062 1067 O
glutamate 130 139 1068 1077 O
levels 140 146 1078 1084 O
at 147 149 1085 1087 O
the 150 153 1088 1091 O
discretion 154 164 1092 1102 O
of 165 167 1103 1105 O
the 168 171 1106 1109 O
PI 172 174 1110 1112 O
such 175 179 1113 1117 O
as 180 182 1118 1120 O
memantine 183 192 1121 1130 B-treatment
, 192 193 1130 1131 O
lamotrigine 194 205 1132 1143 B-treatment
, 205 206 1143 1144 O
lithium 207 214 1145 1152 B-treatment
, 214 215 1152 1153 O
opiates 216 223 1154 1161 B-treatment
, 223 224 1161 1162 O
bupropion 225 234 1163 1172 B-treatment
, 234 235 1172 1173 O
psychostimulants 236 252 1174 1190 B-treatment
such 253 257 1191 1195 O
as 258 260 1196 1198 O
amphetamines 261 273 1199 1211 B-treatment
and 274 277 1212 1215 O
methylphenidate 278 293 1216 1231 B-treatment
, 293 294 1231 1232 O
tricyclic 295 304 1233 1242 B-treatment
antidepressants 305 320 1243 1258 I-treatment
, 320 321 1258 1259 O
benzodiazepines 322 337 1260 1275 B-treatment
and 338 341 1276 1279 O
any 342 345 1280 1283 O
other 346 351 1284 1289 O
drug 352 356 1290 1294 O
that 357 361 1295 1299 O
the 362 365 1300 1303 O
investigators 366 379 1304 1317 O
judge 380 385 1318 1323 O
might 386 391 1324 1329 O
interfere 392 401 1330 1339 O
with 402 406 1340 1344 O
the 407 410 1345 1348 O
study 411 416 1349 1354 O

History 0 7 1355 1362 O
of 8 10 1363 1365 O
brain 11 16 1366 1371 B-chronic_disease
disease 17 24 1372 1379 I-chronic_disease
including 25 34 1380 1389 O
Parkinson 35 44 1390 1399 B-chronic_disease
's 44 46 1399 1401 I-chronic_disease
Disease 47 54 1402 1409 I-chronic_disease
, 54 55 1409 1410 O
severe 56 62 1411 1417 B-chronic_disease
brain 63 68 1418 1423 I-chronic_disease
trauma 69 75 1424 1430 I-chronic_disease
, 75 76 1430 1431 O
seizures 77 85 1432 1440 B-chronic_disease
, 85 86 1440 1441 O
history 87 94 1442 1449 O
of 95 97 1450 1452 O
stroke 98 104 1453 1459 B-chronic_disease
, 104 105 1459 1460 O
clinically 106 116 1461 1471 O
significant 117 128 1472 1483 O
lacunar 129 136 1484 1491 B-chronic_disease
infarct 137 144 1492 1499 I-chronic_disease
in 145 147 1500 1502 O
a 148 149 1503 1504 O
region 150 156 1505 1511 O
important 157 166 1512 1521 O
for 167 170 1522 1525 O
cognition 171 180 1526 1535 O
or 181 183 1536 1538 O
multiple 184 192 1539 1547 O
lacunes 193 200 1548 1555 O
or 201 203 1556 1558 O
a 204 205 1559 1560 O
cortical 206 214 1561 1569 B-chronic_disease
infarct 215 222 1570 1577 I-chronic_disease
or 223 225 1578 1580 O
focal 226 231 1581 1586 O
lesions 232 239 1587 1594 O
of 240 242 1595 1597 O
clinical 243 251 1598 1606 O
significance 252 264 1607 1619 O
, 264 265 1619 1620 O
multiple 266 274 1621 1629 B-chronic_disease
sclerosis 275 284 1630 1639 I-chronic_disease
, 284 285 1639 1640 O
mental 286 292 1641 1647 B-chronic_disease
retardation 293 304 1648 1659 I-chronic_disease
, 304 305 1659 1660 O
normal 306 312 1661 1667 B-chronic_disease
pressure 313 321 1668 1676 I-chronic_disease
hydrocephalus 322 335 1677 1690 I-chronic_disease
, 335 336 1690 1691 O
central 337 344 1692 1699 B-cancer
nervous 345 352 1700 1707 I-cancer
system 353 359 1708 1714 I-cancer
( 360 361 1715 1716 I-cancer
CNS 361 364 1716 1719 I-cancer
) 364 365 1719 1720 I-cancer
tumor 366 371 1721 1726 I-cancer
, 371 372 1726 1727 O
Huntington 373 383 1728 1738 B-chronic_disease
's 383 385 1738 1740 I-chronic_disease
disease 386 393 1741 1748 I-chronic_disease
, 393 394 1748 1749 O
subdural 395 403 1750 1758 B-chronic_disease
hematoma 404 412 1759 1767 I-chronic_disease
or 413 415 1768 1770 O
other 416 421 1771 1776 O
serious 422 429 1777 1784 O
neurological 430 442 1785 1797 B-chronic_disease
disorder 443 451 1798 1806 I-chronic_disease

Lactose 0 7 1807 1814 B-chronic_disease
intolerance 8 19 1815 1826 I-chronic_disease

MRI 0 3 1827 1830 B-allergy_name
contraindication 4 20 1831 1847 O
( 21 22 1848 1849 O
severe 22 28 1849 1855 O
claustrophobia 29 43 1856 1870 B-chronic_disease
, 43 44 1870 1871 O
metal 45 50 1872 1877 B-allergy_name
implants 51 59 1878 1886 I-allergy_name
, 59 60 1886 1887 O
shunts 61 67 1888 1894 B-allergy_name
, 67 68 1894 1895 O
pacemaker 69 78 1896 1905 B-allergy_name
, 78 79 1905 1906 O
joint 80 85 1907 1912 B-allergy_name
implants 86 94 1913 1921 I-allergy_name
, 94 95 1921 1922 O
metal 96 101 1923 1928 B-allergy_name
valves 102 108 1929 1935 I-allergy_name
) 108 109 1935 1936 O

Male 0 4 1937 1941 B-gender

Must 0 4 1942 1946 O
be 5 7 1947 1949 O
fluent 8 14 1950 1956 B-language_fluency
in 15 17 1957 1959 I-language_fluency
English 18 25 1960 1967 I-language_fluency

Must 0 4 1968 1972 O
be 5 7 1973 1975 O
on 8 10 1976 1978 O
donepezil 11 20 1979 1988 B-treatment
( 21 22 1989 1990 I-treatment
Aricept 22 29 1990 1997 I-treatment
® 29 30 1997 1998 I-treatment
) 30 31 1998 1999 I-treatment
or 32 34 2000 2002 O
rivastigmine 35 47 2003 2015 B-treatment
( 48 49 2016 2017 I-treatment
Exelon 49 55 2017 2023 I-treatment
® 55 56 2023 2024 I-treatment
) 56 57 2024 2025 I-treatment
or 58 60 2026 2028 O
galantamine 61 72 2029 2040 B-treatment
( 73 74 2041 2042 I-treatment
Razadyne 74 82 2042 2050 I-treatment
® 82 83 2050 2051 I-treatment
) 83 84 2051 2052 I-treatment
at 85 87 2053 2055 O
a 88 89 2056 2057 O
consistent 90 100 2058 2068 O
dose 101 105 2069 2073 O
for 106 109 2074 2077 O
at 110 112 2078 2080 O
least 113 118 2081 2086 O
2 119 120 2087 2088 B-lower_bound
months 121 127 2089 2095 I-lower_bound

Participation 0 13 2096 2109 O
in 14 16 2110 2112 O
any 17 20 2113 2116 O
investigational 21 36 2117 2132 O
or 37 39 2133 2135 O
marketed 40 48 2136 2144 O
drug 49 53 2145 2149 O
or 54 56 2150 2152 O
device 57 63 2153 2159 O
trial 64 69 2160 2165 O
within 70 76 2166 2172 O
30 77 79 2173 2175 B-upper_bound
days 80 84 2176 2180 I-upper_bound
prior 85 90 2181 2186 I-upper_bound
to 91 93 2187 2189 O
the 94 97 2190 2193 O
screening 98 107 2194 2203 O
visit 108 113 2204 2209 O

Previous 0 8 2210 2218 O
riluzole 9 17 2219 2227 B-treatment
treatment 18 27 2228 2237 I-treatment

Serum 0 5 2238 2243 B-clinical_variable
creatinine 6 16 2244 2254 I-clinical_variable
> 17 18 2255 2256 O
1.5 18 21 2256 2259 B-lower_bound
times 22 27 2260 2265 I-lower_bound
the 28 31 2266 2269 I-lower_bound
upper 32 37 2270 2275 I-lower_bound
limit 38 43 2276 2281 I-lower_bound
of 44 46 2282 2284 I-lower_bound
normal 47 53 2285 2291 I-lower_bound

Severe 0 6 2292 2298 B-chronic_disease
Alzheimer 7 16 2299 2308 I-chronic_disease
's 16 18 2308 2310 I-chronic_disease
disease 19 26 2311 2318 I-chronic_disease
and 27 30 2319 2322 O
other 31 36 2323 2328 O
dementias 37 46 2329 2338 B-chronic_disease
as 47 49 2339 2341 O
determined 50 60 2342 2352 O
by 61 63 2353 2355 O
neuropsychological 64 82 2356 2374 B-clinical_variable
testing 83 90 2375 2382 I-clinical_variable
and 91 94 2383 2386 O
neurological 95 107 2387 2399 B-clinical_variable
evaluation 108 118 2400 2410 I-clinical_variable

Significant 0 11 2411 2422 O
neuropsychiatric 12 28 2423 2439 B-chronic_disease
illnesses 29 38 2440 2449 I-chronic_disease
such 39 43 2450 2454 O
as 44 46 2455 2457 O
bipolar 47 54 2458 2465 B-chronic_disease
disorder 55 63 2466 2474 I-chronic_disease
, 63 64 2474 2475 O
schizophrenia 65 78 2476 2489 B-chronic_disease
, 78 79 2489 2490 O
moderate 80 88 2491 2499 B-chronic_disease
- 88 89 2499 2500 I-chronic_disease
severe 89 95 2500 2506 I-chronic_disease
anxiety 96 103 2507 2514 I-chronic_disease
, 103 104 2514 2515 O
vascular 105 113 2516 2524 B-chronic_disease
dementia 114 122 2525 2533 I-chronic_disease
, 122 123 2533 2534 O
Creutzfeldt 124 135 2535 2546 B-chronic_disease
- 135 136 2546 2547 I-chronic_disease
Jakob 136 141 2547 2552 I-chronic_disease
dementia 142 150 2553 2561 I-chronic_disease
, 150 151 2561 2562 O
HIV 152 155 2563 2566 B-chronic_disease
dementia 156 164 2567 2575 I-chronic_disease
, 164 165 2575 2576 O
and 166 169 2577 2580 O
dementia 170 178 2581 2589 O
in 179 181 2590 2592 O
other 182 187 2593 2598 O
specified 188 197 2599 2608 O
diseases 198 206 2609 2617 O

Subject 0 7 2618 2625 O
must 8 12 2626 2630 O
not 13 16 2631 2634 O
be 17 19 2635 2637 O
taking 20 26 2638 2644 O
Namenda 27 34 2645 2652 B-treatment
® 34 35 2652 2653 I-treatment
( 36 37 2654 2655 I-treatment
memantine 37 46 2655 2664 I-treatment
) 46 47 2664 2665 I-treatment
for 48 51 2666 2669 O
6 52 53 2670 2671 B-upper_bound
- 53 54 2671 2672 I-upper_bound
weeks 54 59 2672 2677 I-upper_bound
prior 60 65 2678 2683 I-upper_bound
to 66 68 2684 2686 O
study 69 74 2687 2692 O
entrance 75 83 2693 2701 O

Subjects 0 8 2702 2710 O
who 9 12 2711 2714 O
have 13 17 2715 2719 O
been 18 22 2720 2724 O
on 23 25 2725 2727 O
donepezil 26 35 2728 2737 B-treatment
for 36 39 2738 2741 O
longer 40 46 2742 2748 O
than 47 51 2749 2753 O
5 52 53 2754 2755 B-lower_bound
years 54 59 2756 2761 I-lower_bound

Uncontrolled 0 12 2762 2774 O
diabetes 13 21 2775 2783 B-chronic_disease
mellitus 22 30 2784 2792 I-chronic_disease
( 31 32 2793 2794 O
Hba1c 32 37 2794 2799 B-clinical_variable
higher 38 44 2800 2806 O
than 45 49 2807 2811 O
7 50 51 2812 2813 B-lower_bound
) 51 52 2813 2814 O
or 53 55 2815 2817 O
chronically 56 67 2818 2829 O
uncontrolled 68 80 2830 2842 O
hypertension 81 93 2843 2855 B-chronic_disease

Weight 0 6 2856 2862 B-clinical_variable
> 6 7 2862 2863 O
300 8 11 2864 2867 B-lower_bound
pounds 12 18 2868 2874 I-lower_bound

bilirubin 0 9 2875 2884 B-clinical_variable
> 10 11 2885 2886 O
1.5 11 14 2886 2889 B-lower_bound
times 15 20 2890 2895 I-lower_bound
the 21 24 2896 2899 I-lower_bound
upper 25 30 2900 2905 I-lower_bound
limit 31 36 2906 2911 I-lower_bound
of 37 39 2912 2914 I-lower_bound
normal 40 46 2915 2921 I-lower_bound

female 0 6 2922 2928 B-gender

previously 0 10 2929 2939 O
unable 11 17 2940 2946 O
to 18 20 2947 2949 O
tolerate 21 29 2950 2958 O
acetylcholinesterase 30 50 2959 2979 B-allergy_name
inhibitors 51 61 2980 2990 I-allergy_name
and 62 65 2991 2994 O
as 66 68 2995 2997 O
a 69 70 2998 2999 O
result 71 77 3000 3006 O
, 77 78 3006 3007 O
are 79 82 3008 3011 O
no 83 85 3012 3014 O
longer 86 92 3015 3021 O
on 93 95 3022 3024 O
the 96 99 3025 3028 O
medication 100 110 3029 3039 O
for 111 114 3040 3043 O
at 115 117 3044 3046 O
least 118 123 3047 3052 O
2 124 125 3053 3054 B-lower_bound
months 126 132 3055 3061 I-lower_bound

with 0 4 3062 3066 O
mild 5 9 3067 3071 B-chronic_disease
Alzheimer 10 19 3072 3081 I-chronic_disease
's 19 21 3081 3083 I-chronic_disease
disease 22 29 3084 3091 I-chronic_disease
determined 30 40 3092 3102 O
after 41 46 3103 3108 O
neurological 47 59 3109 3121 O
and 60 63 3122 3125 O
neuropsychological 64 82 3126 3144 O
evaluation 83 93 3145 3155 O
following 94 103 3156 3165 O
the 104 107 3166 3169 O
National 108 116 3170 3178 O
Institute 117 126 3179 3188 O
on 127 129 3189 3191 O
Aging 130 135 3192 3197 O
- 136 137 3198 3199 O
Alzheimer 138 147 3200 3209 O
's 147 149 3209 3211 O
disease 150 157 3212 3219 O
Association 158 169 3220 3231 O
criteria 170 178 3232 3240 O
that 179 183 3241 3245 O
recently 184 192 3246 3254 O
revisited 193 202 3255 3264 O
the 203 206 3265 3268 O
NINCDS 207 213 3269 3275 O
- 213 214 3275 3276 O
ADRDA 214 219 3276 3281 O
criteria 220 228 3282 3290 O

